Oligonucleotides comprising a modified or non-natural nucleobase

Details for Australian Patent Application No. 2005328382 (hide)

Owner Alnylam Pharmaceuticals, Inc.

Inventors Xia, Jie; Manoharan, Muthiah; Rajeev, Kallanthottathil G.

Agent Griffith Hack

Pub. Number AU-B-2005328382

PCT Pub. Number WO2006/093526

Priority 60/598,596 04.08.04 US; 60/614,111 29.09.04 US; 60/589,632 21.07.04 US

Filing date 21 July 2005

Wipo publication date 8 September 2006

Acceptance publication date 13 September 2012

International Classifications

C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 31/7115 - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/093526 Priority application(s): WO2006/093526

13 September 2012 Application Accepted

  Published as AU-B-2005328382

4 October 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 12 Sep 2012 . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060 2006

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005328387-System and method for network-based object authentication

2005328371-Hybrid electric propulsion system and method